Gosset Ownership
Private
Employees
~41
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Provisio Medical General Information
Provisio Medical has developed the SLT IVUS™ System, a novel intravascular ultrasound technology that enables accurate vessel sizing during endovascular procedures. The system received FDA clearance in April/May 2024 and is designed to improve clinical outcomes by providing real-time, user-independent measurements for physicians treating vascular diseases. The company is now commercializing its technology and expanding manufacturing capabilities.
Contact Information
Website
Primary Industry
Medical Imaging
Corporate Office
San Diego, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
MedTech Innovator (investor/partner), PBO Advisory Group (finance/accounting support partner)
Provisio Medical Funding
No funding data available
To view Provisio Medical's complete valuation and funding history, request access »